Market By Age Group, Education, Drugs & Devices, End Users And Geography | Forecasts 2019-2027
As per the research conducted by Triton, the Asia-Pacific contraceptive market is expected to reach at a CAGR of 7.70% during the forecast period 2019-2027.
The countries covered in this region are:
O China
O New Zealand
O Japan
O Australia
O India
O South Korea
O ASEAN countries
O rest of APAC
The research report contains necessary information about the market definition, Pestel’s outlook, key insights, Porter's five force analysis, market attractiveness index and the regulatory outlook.
The countries in the Asia-Pacific regions, especially the developing ones such as China and India, have been grappling with issues such as overpopulation. Thus, to keep population growth under check, the national governments have come up with initiatives to spread awareness about the importance of family planning and birth control. The contraceptive market is being driven by the easy availability of OTC oral contraceptive pills. The rising incidences of STIs have made individuals cautious and have thus led to many of them adopting contraceptive techniques as a preventive measure.
In spite of all these advantages offered by them, factors such as lack of acceptance faced by contraceptives are impeding the market growth. Socio-cultural opposition for the use of contraceptives in countries having conservative populations is a major restraining factor. Moreover, lack of accessibility and misperceptions about the use of contraceptives are some of the challenges faced by the contraceptive industry.
The Asia-Pacific contraceptive market has been segregated into various categories based on age groups, education, drugs & devices and end users. Companies such as Cooper Surgical, Inc., Merck & Co., Inc., Church & Dwight Co., Inc., Teva Pharmaceutical Industries, Ltd., Apothecus Pharmaceutical Corporation, Pregna, Pfizer, Inc., Bayer AG, Melbea, SMB Corporation, Reckitt Benckiser PLC, Mayer Laboratories, Inc., Ocon Medical, Ltd., Okamoto Industries, Inc., Afaxys, Inc., Allergan, Inc. and Agile Therapeutics have been the leading manufacturers of contraceptives.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. CONTRACEPTIVE
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. REGULATORY
OUTLOOK
2.4. PESTEL
OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. MARKET
PLAYER POSITIONING
2.7. KEY
INSIGHTS
2.7.1. ORAL
CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS
2.7.2. CONDOMS
ARE THE WIDELY USED CONTRACEPTIVES DEVICE
2.7.3. AGE
GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE ASIA-PACIFIC
CONTRACEPTIVE MARKET
2.8. MARKET
DRIVERS
2.8.1. GROWING
COGNIZANCE FOR CONTRACEPTIVES
2.8.2. INCREASING
USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY
2.8.3. SURGE
IN THE INITIATIVES OF GOVERNMENT AND NGO
2.8.4. GROWING
AWARENESS ABOUT STD
2.9. MARKET
RESTRAINTS
2.9.1. SIDE
EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES
2.9.2. LIMITED
ACCESS TO CONTRACEPTIVES
2.10.
MARKET OPPORTUNITIES
2.10.1.
RISING DISPOSABLE INCOME IN
EMERGING ECONOMIES
2.10.2.
UNMET MEDICAL NEEDS IN THE
EMERGING ECONOMIES
2.10.3.
TECHNOLOGICAL ADVANCEMENTS
2.11.
MARKET CHALLENGES
2.11.1.
LACK OF ACCEPTANCE OF SOCIETY
3. CONTRACEPTIVE
MARKET OUTLOOK - BY EDUCATION
3.1. LESS
THAN HIGH SCHOOL
3.2. HIGH
SCHOOL GRADUATE
3.3. COLLEGE
GRADUATE
3.4. OTHER
COLLEGE DEGREES
4. CONTRACEPTIVE
MARKET OUTLOOK - BY AGE GROUP
4.1. 15–24
YEARS
4.2. 25–34
YEARS
4.3. 35–44
YEARS
4.4. ABOVE
44 YEARS
5. CONTRACEPTIVE
MARKET OUTLOOK - BY END USER
5.1. HOUSEHOLDS
5.2. CLINICS
5.3. HOSPITALS
6. CONTRACEPTIVE
MARKET OUTLOOK - BY DRUGS AND DEVICES
6.1. CONTRACEPTIVES
DRUGS
6.1.1. ORAL
CONTRACEPTIVE PILLS
6.1.2. INJECTABLE
CONTRACEPTIVES
6.1.3. TOPICAL
CONTRACEPTIVES
6.2. CONTRACEPTIVE
DEVICES
6.2.1. MALE
CONDOMS
6.2.2. FEMALE
CONDOMS
6.2.3. DIAPHRAGMS
6.2.4. CONTRACEPTIVE
SPONGES
6.2.5. VAGINAL
RINGS
6.2.6. SUBDERMAL
IMPLANTS
6.2.7. INTRA-UTERINE
DEVICES
6.2.7.1. COPPER
INTRA-UTERINE DEVICES
6.2.7.2. HORMONAL
INTRA-UTERINE DEVICES
7. CONTRACEPTIVE
MARKET - REGIONAL OUTLOOK
7.1. ASIA-PACIFIC
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. JAPAN
7.1.1.2. CHINA
7.1.1.3. INDIA
7.1.1.4. AUSTRALIA
& NEW ZEALAND
7.1.1.5. SOUTH
KOREA
7.1.1.6. ASEAN
COUNTRIES
7.1.1.7. REST
OF ASIA-PACIFIC
8. COMPETITIVE
LANDSCAPE
8.1. COMPANY
PROFILES
8.1.1. ALLERGAN
INC.
8.1.2. BAYER
AG
8.1.3. MELBEA
8.1.4. PREGNA
8.1.5. PFIZER,
INC.
8.1.6. CHURCH
& DWIGHT CO., INC.
8.1.7. AFAXYS,
INC.
8.1.8. APOTHECUS
PHARMACEUTICAL CORPORATION
8.1.9. COOPER
SURGICAL INC
8.1.10.
OKAMOTO INDUSTRIES, INC
8.1.11.
MAYER LABORATORIES, INC.
8.1.12.
AGILE THERAPEUTICS
8.1.13.
MERCK & CO., INC.
8.1.14.
RECKITT BENCKISER PLC
8.1.15.
SMB CORPORATION
8.1.16.
TEVA PHARMACEUTICAL INDUSTRIES
LTD.
8.1.17.
OCON MEDICAL LTD
9. METHODOLOGY
& SCOPE
9.1. RESEARCH
SCOPE
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1 ASIA-PACIFIC CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
TABLE 2 CONTRACEPTIVE MARKET PLAYER POSITIONING OUTLOOK 2017
TABLE 3 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
EDUCATION 2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC CONTRACEPTIVE MARKET BY AGE
GROUP 2019-2027 ($ MILLION)
TABLE 5 ASIA-PACIFIC CONTRACEPTIVE MARKET BY END
USER 2019-2027 ($ MILLION)
TABLE 6 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 7 ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET
BY TYPE 2019-2027 ($ MILLION)
TABLE 8 ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS
MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA-PACIFIC INJECTABLE
CONTRACEPTIVESMARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA-PACIFIC TOPICAL CONTRACEPTIVESMARKET
2019-2027 ($ MILLION)
TABLE 11 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET
BY TYPE 2019-2027 ($ MILLION)
TABLE 12 ASIA-PACIFIC INTRA-UTERINE DEVICES MARKET
BY TYPE 2019-2027 ($ MILLION)
TABLE 13 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 ASIA-PACIFIC CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 2 PORTER’S FIVE FORCE MODEL
FIGURE 3 ASIA-PACIFIC CONTRACEPTIVE MARKET BY LESS
THAN HIGH SCHOOL 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC CONTRACEPTIVE MARKET BY HIGH
SCHOOL GRADUATE 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
COLLEGE GRADUATE 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC CONTRACEPTIVE MARKET BY OTHER
COLLEGE DEGREES 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC CONTRACEPTIVE MARKET BY 15–24
YEARS 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC CONTRACEPTIVE MARKET BY 25–34
YEARS 2019-2027 ($ MILLION)
FIGURE 9 ASIA-PACIFIC CONTRACEPTIVE MARKET BY 35–44
YEARS 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC CONTRACEPTIVE MARKET BY ABOVE 44
YEARS 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
HOUSEHOLDS 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC CONTRACEPTIVE MARKET BY CLINICS
2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
HOSPITALS 2019-2027 ($ MILLION)
FIGURE 14 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)
FIGURE 15 ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY
ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY
INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC CONTRACEPTIVES DRUGS MARKET BY
TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC CONTRACEPTIVE MARKET BY
CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)
FIGURE 19 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
MALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 20 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
FEMALE CONDOMS 2019-2027 ($ MILLION)
FIGURE 21 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
DIAPHRAGMS 2019-2027 ($ MILLION)
FIGURE 22 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)
FIGURE 23 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
VAGINAL RINGS 2019-2027 ($ MILLION)
FIGURE 24 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)
FIGURE 25 ASIA-PACIFIC CONTRACEPTIVE DEVICES MARKET BY
INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 26 ASIA-PACIFIC INTRA-UTERINE DEVICES MARKET BY
COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 27 ASIA-PACIFIC INTRA-UTERINE DEVICES MARKET BY
HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)
FIGURE 28 JAPAN CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 29 CHINA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 30 INDIA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 31 AUSTRALIA & NEW ZEALAND CONTRACEPTIVE
MARKET 2019-2027 ($ MILLION)
FIGURE 32 SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($
MILLION)
FIGURE 33 ASEAN COUNTRIES CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)
FIGURE 34 REST OF ASIA-PACIFIC CONTRACEPTIVE MARKET
2019-2027 ($ MILLION)